BRCA2 and breast carcinoma: Indeed, the proportion of BRCA1- and BRCA2-deficient breast cancers with biallelic pathogenic germline mutations was significantly higher in WSI compared to TCGA whereas the proportion of BRCA1- and BRCA2-deficient breast cancers with biallelic pathogenic somatic mutations was not significantly different between the two cohorts.